Nonmyeloablative trans- plant protocol. PBSCT, peripheral blood stem cells transplant; DLI*, donor lymphocyte infusion. Patients received incremental doses of lymphocytes every 30 days until 100% donor T-cell chimerism, AGVHD, graft rejection, or a disease response occurred.